$10B Illinois Tobacco Lawsuit Revival
Illinois $10 billion class action against Philip Morris over deceptive light cigarettes gains new life after years of legal battles.
The long-standing battle between Illinois consumers and Philip Morris over allegedly deceptive “light” cigarette marketing has taken a dramatic turn. A class action lawsuit seeking $10 billion in damages, originally filed on behalf of purchasers since 1971, was recently reinstated, reigniting debates on corporate accountability in the tobacco industry. This case underscores the persistent legal scrutiny faced by tobacco giants for misleading health claims.
Origins of the Deceptive Marketing Allegations
The lawsuit stems from claims that Philip Morris violated the Illinois Consumer Fraud and Deceptive Business Practices Act by promoting light and low-tar cigarettes as healthier alternatives to regular brands. Plaintiffs argue that these products were marketed to suggest reduced health risks, despite internal research allegedly showing otherwise. Sharon Price, the lead plaintiff, represents a class of Illinois residents who bought these cigarettes starting from 1971, alleging widespread deception that influenced purchasing decisions.
Throughout the 1970s and beyond, tobacco companies faced mounting evidence of manipulative advertising. Federal Trade Commission guidelines played a pivotal role, as courts examined whether descriptors like “lights” implied safety without explicit FTC prohibition. This case highlights how marketing tactics exploited consumer trust, leading to prolonged exposure to harmful products under false pretenses of lower risk.
Timeline of Judicial Rollercoaster
The litigation’s history is marked by reversals and reinstatements. In 2005, a trial court awarded the $10 billion judgment, but the Illinois Supreme Court overturned it, citing FTC allowances for “lights” terminology. Critics pointed to potential bias involving Justice Lloyd A. Karmeier, whose 2004 campaign reportedly benefited from Philip Morris parent company ads, though the company denies direct contributions.
Reinstatement came in 2014, only for another rejection in recent years. Philip Morris urged the U.S. Supreme Court to decline review, emphasizing no campaign contributions and prior state court rulings. The case, docketed as Price et al. v. Philip Morris Inc., No. 15-947, continues to test appellate boundaries.
The Future of AI: Preventing a Big Tech Monopoly >
- 2005: Initial $10B judgment reversed by Illinois Supreme Court.
- 2014: Judgment reinstated amid bias allegations.
- Recent: Latest rejection, with plaintiffs pushing for U.S. Supreme Court intervention.
Broader Context of Tobacco Litigation in America
This Illinois action is part of a larger wave of tobacco accountability suits. The 1998 Master Settlement Agreement (MSA) saw 46 states settle with major manufacturers for over $206 billion over 25 years, addressing Medicaid costs from smoking-related illnesses. Illinois received $9.1 billion total, including $804 million in 2022 payments, with restrictions on youth-targeted marketing like cartoons.
Non-MSA states like Florida, Minnesota, Mississippi, and Texas secured separate deals prior. The MSA dissolved industry fronts such as the Tobacco Institute and funded anti-smoking efforts via the Truth Initiative. Despite this, private class actions persist, as the MSA did not immunize companies from individual or consumer suits.
| Settlement | Parties Involved | Key Outcomes | Value |
|---|---|---|---|
| Master Settlement Agreement (1998) | 46 states vs. Philip Morris, R.J. Reynolds, etc. | Marketing limits, annual payments, youth protections | $206B+ over 25 years |
| Illinois Tobacco Case (Ongoing) | Consumers vs. Philip Morris | $10B sought for deceptive lights marketing | $10B (disputed) |
| Massachusetts Verdict (2023) | Family vs. Philip Morris | $37M upheld for light cigarette harms | $37M |
Recent Tobacco Victories and Their Implications
Courts continue delivering blows to tobacco firms. In 2023, Massachusetts’ Supreme Judicial Court upheld a $37 million award to a cancer victim’s family, including $25 million for pain and $150 million punitive, finding Philip Morris concealed dangers of light cigarettes. Attorney Walter Kelley secured this win, proving ongoing liability.
Federally, a 2006 RICO case by the U.S. Department of Justice against Philip Morris and others resulted in Judge Gladys Kessler ordering corrective advertising admissions of deception on addiction and secondhand smoke dangers. Companies must fund point-of-sale warnings at 220,000 retailers.
These rulings affirm that even post-MSA, tobacco firms face reckoning for fraud. A 1997 proposed global settlement evolved into the MSA but lacked immunity, leading to verdicts totaling $184 billion by early 2000s, exceeding initial proposals.
Challenges for Plaintiffs in Class Actions
Class certification hinges on commonality of harm. In the Illinois case, proving uniform deception across decades-long purchases is complex, compounded by FTC stances on descriptors. Defendants argue no fraud, as lights delivered on tar measurements via machine testing, though plaintiffs counter real-world smoking bypassed filters.
Judicial bias claims add intrigue. Plaintiffs cite ads supporting Karmeier, potentially tainting the 2005 reversal. Philip Morris counters with records showing no donations, urging finality.
Impact on Public Health and Policy
Tobacco litigation has driven smoking declines, from 42% in 1965 to under 12% today, partly via MSA-funded programs. Annual U.S. deaths: 440,000; costs: $157 billion pre-MSA estimates.
Illinois uses MSA funds for healthcare, but consumer suits like this push for direct restitution. Recent payments, like $258 million plus $546 million released in 2022, bolster state resources.
Legal Strategies and Representation
Plaintiffs rely on firms like Korein Tillery LLC (Stephen M. Tillery) and Kellogg Huber (David C. Frederick, Jeremy S. Newman). Strategies include RICO violations, fraud statutes, and evidence of concealed research.
Tobacco defenses invoke preemption by federal law, settlement releases, and First Amendment protections for commercial speech. U.S. Supreme Court review could clarify these.
Future Prospects for the $10B Claim
If revived, this could set precedent for similar suits nationwide, pressuring further disclosures. Philip Morris seeks closure, but plaintiffs eye accountability. Monitoring U.S. Supreme Court docket is key.
Frequently Asked Questions
What is the basis of the $10B Illinois tobacco lawsuit?
It accuses Philip Morris of fraudulently marketing light cigarettes as healthier since 1971, violating state consumer laws.
Has the judgment been awarded?
A trial court awarded $10B in 2005, reinstated 2014, but overturned again; revival efforts continue.
How does this relate to the 1998 MSA?
The MSA settled state healthcare claims but not private consumer class actions like this.
Are there recent tobacco wins?
Yes, $37M in Massachusetts (2023) and ongoing RICO remedies.
Can individuals still sue tobacco companies?
Yes, for personal injuries if within statutes of limitations, often via product liability.
References
- Philip Morris Urges Supreme Court to Keep $10B Judgment Dead — Top Class Actions. 2016. https://topclassactions.com/lawsuit-settlements/lawsuit-news/philip-morris-urges-supreme-court-keep-10b-judgment-dead/
- Tobacco Product Liability Lawsuit — Bernheim Kelley Injury Lawyers / WBUR. 2023. https://realjustice.com/mass-tort/tobacco-product-liability-lawsuit/
- Tobacco Settlement — Illinois Attorney General. 2022. https://illinoisattorneygeneral.gov/tobacco/
- Big Tobacco Lawsuit — American Cancer Society. 2006. https://www.fightcancer.org/what-we-do/big-tobacco-lawsuit
- Tobacco Master Settlement Agreement — National Association of Attorneys General. N/A. https://www.naag.org/our-work/naag-center-for-tobacco-and-public-health/the-master-settlement-agreement/
- The “Global Settlement” With the Tobacco Industry: 6 Years Later — PMC / American Journal of Public Health. 2003-09-01. https://pmc.ncbi.nlm.nih.gov/articles/PMC1448231/
Similar Articles
Read full bio of medha deb
